Recent Headlines & Media Mentions
Company News
Goal is to develop an end-to-end multimodal imaging workflow designed to support patient assessment, surgical planning, BCI implantation and long-term outcomes
Oct 26, 2026
Paradromics Receives FDA Approval to Expand Connexus® Brain-Computer Interface Clinical Study Recruitment Nationwide
Updated protocol removes four-hour geographic restriction and opens a path to broader participation through three U.S. academic medical centers
Paradromics' brain-computer interface shows 4+ years of stable neural recording and decoding in preclinical studies, combining performance with durability.
Aug 26, 2026
Paradromics Receives FDA Approval to Expand BCI Access to Personal Computing Devices in Connect-One™ Clinical Study
Expanded device pathway advances development of the Paradromics BCI platform toward greater mobility, independence, and everyday digital access
Neurologist, clinical scientist, and former Verily leader joins Paradromics as company advances first-in-human clinical study
Thought Leadership
Looking for additional insights, industry findings, and scientific deep dives?